2019 Medtronic China Fund & BV Healthcare Robotics Competition Crowned Champion Among Nine Finalists

The 2019 Medical Robot Competition, hosted by the Medtronic China Foundation and BV Baidu Venture Capital and organized by VCBeat, has attracted extensive participation from dozens of projects submitted by enterprises, universities, laboratories, and other institutions since its launch in April this year, leveraging its professional technical foundation and strong application background. After three months of rigorous screening, nine outstanding projects from the three major fields—surgical robots, rehabilitation robots, and assistive robots—successfully passed the judges’ stringent review and advanced to the finals.

On July 13, 2019, the grand finals of this Medical Robotics Competition will be held at the Pujiang High-Tech Park in Lingang, Shanghai. The top nine projects will converge in Shanghai to compete for the top three positions. A judging panel composed of technical leaders in artificial intelligence and robotics, clinical experts, executives from medical technology companies and venture capital firms, government representatives, and senior industry observers will conduct a comprehensive review and evaluation. The assessment will cover multiple dimensions, including project perspective, problem-solving approach, service scope, service capacity, technological advantages, resource reserves, feasibility, and team strength, to determine the final rankings.

Centered on the theme of “medical robots,” this competition required participating projects to leverage technologies such as AI, sensors, robotics, and 3D imaging to propose innovative solutions with breakthrough creativity that better address challenges in clinical settings. Among the finalists, surgical robots accounted for 56%, constituting the dominant category of entries.

In recent years, the development of domestic abdominal and orthopedic surgical robots in China has been on the right track, with local companies such as Tinavi achieving clinical and commercial breakthroughs. In addition to these two major fields, there is an urgent demand for surgical robots in many niche areas. Future market opportunities will emerge in specialties such as otolaryngology, neurosurgery, and ophthalmology, leading to a more diversified and specialized development of the overall surgical robot market.

Compared with the surgical robot market, assistive robots are currently the primary focus of research and development for domestic robotics companies and institutions. According to the VCBeat database, dozens of robotics enterprises are engaged in R&D in this field; some have already received regulatory approval for hospital deployment and generated sales revenue, while other projects still in the R&D phase have also attracted significant interest from capital markets and industry stakeholders. Assistive robots account for 22% of the robots shortlisted this time, including Huxi Yunbaisheng’s cardiac surgery screening system and Zhongzhi Daxin’s Dorik AI Physician Assistance Platform.

Rehabilitation has emerged as a highly prominent sector in recent years, with rehabilitation robots accounting for 11% of the shortlisted companies in this competition. China started developing rehabilitation robots relatively early, and many enterprises already have mature products available on the market. However, most rehabilitation robotic devices currently available are designed for hospital use, making them unaffordable for ordinary patients. Therefore, cost-effective, economical rehabilitation robots are likely to see significant market growth in the future.

Driven by sustained policy support and capital investment, various types of medical robots have become effective technological means to enhance the efficiency of healthcare services. It is hoped that the nine shortlisted projects will emerge as the core driving force of China’s robotics industry over the next decade.

The competition also received strategic support from the Shanghai Minhang District Science and Technology Commission, Shanghai Lingang Pujiang International Technology City, the Medical Robotics Institute of Shanghai Jiao Tong University, the Medical-Engineering Integration Alliance, the Suzhou Collaborative Innovation Institute for Medical Robots, and the High-Precision Innovation Center for Biomedical Engineering at Beihang University. Experts and leaders from these fields will join a judging panel led by Mr. Gu Yushao, President of Medtronic Greater China; Mr. Zhu Feng, Director at BV Baidu Ventures; Professor Wang Tianmiao from Beihang University; and Mr. Gu Jianping, Deputy Director of the Minhang District Science and Technology Commission. This authoritative panel, encompassing expertise in technology, clinical practice, and market dynamics, aims to identify medical robotics innovations with genuine clinical value and market potential.

All finalists in this competition are expected to gain access to investment opportunities from BV Baidu Ventures and the Medtronic China Fund, priority incubation through the Medtronic Innovation Accelerator, and partnership matchmaking with Medtronic China’s core business units.

To further promote the integration of industry, academia, and research, a limited number of non-investor observer slots for the on-site event are open to innovative medical robotics companies, hospital administrators, and university students. Please scan the QR code to apply for admission tickets. Upon review and approval by the organizers, you will receive an SMS notification containing details such as the date, venue, and entry instructions for the grand finals. Failure to receive such notification indicates that your application has not been approved.

Scan QR Code to Register